10x Genomics appoints Alan V. Mateo to Board of Directors

10x Genomics, Inc.

Alan V. Mateo appointed as Class II director effective June 18, 2024, term until 2027 annual meeting.
Mateo previously Executive VP Global Sales at Veeva Systems, executive roles at Medidata Solutions and PeopleSoft.
Receives $55k annual cash retainer, $400k initial RSU grant (July 31, 2024), and $215k annual RSU grant.
Compensation includes standard indemnification agreement; eligible for additional committee service retainers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan V. Mateo

Director

TXG · 10x Genomics, Inc.

Effective: 2024-06-18
Filed: June 20, 2024, 7:59 PM ET

appointed Alan V. Mateo to the Board of Directors as a Class II director effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Alan V. Mateo was appointed as Director at 10x Genomics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Alan V. Mateo to the Board of Directors as a Class II director effective immediately

View on SEC.gov

10x Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001770787-24-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.